Daniel Grosslight
Citigroup | Healthcare
Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector. Ranked #1459 out of 4370 analysts, they have issued 21 stock ratings with a success rate of 95.11% and an average return of 9.23%.
Daniel Grosslight has a well-established track record, with 21 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 95.11% and an average return of 9.23%, underscoring their expertise and ability to identify winning opportunities for investors.
Recent Ratings Analysis
TDOC
HoldOct 21, 2025
Target
$10.50
Current
$8.66
Performance
0.00%
Daniel Grosslight rated TDOC as Neutral on Oct 21, 2025, setting a price target of 10.5. The Hold stance appears justified, as shares hovered around 8.66 with a 0.00% move.
CTEV
BuyOct 21, 2025
Target
$55.00
Current
$66.00
Performance
0.00%
On Oct 21, 2025, CTEV was given a Buy rating by Daniel Grosslight, with a target price of 55. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.
MCK
BuySep 24, 2025
Target
$860.00
Current
$787.29
Performance
3.51%
MCK received a Buy rating from Daniel Grosslight on Sep 24, 2025, aiming for 860. Price action was muted, as shares hovered around 787.29 despite the bullish outlook.
OMI
BuyAug 12, 2025
Target
$7.00
Current
$5.06
Performance
-7.50%
On Aug 12, 2025, Daniel Grosslight published a Buy outlook on OMI, with a target of 7. Market action contradicted the Buy thesis, as shares slipped to 5.06.
HCAT
HoldAug 08, 2025
Target
$3.50
Current
$3.18
Performance
12.37%
Daniel Grosslight on Aug 08, 2025 assigned HCAT a Neutral rating, with a price target of 3.5. Shares outperformed expectations, climbing 12.37% despite the neutral view.
AGL
HoldAug 06, 2025
Target
$1.00
Current
$0.94
Performance
5.67%
On Aug 06, 2025, Daniel Grosslight reaffirmed AGL with a Neutral rating, targeting 1. Market strength beyond 0.9405 went further than the conservative outlook suggested.
WAY
BuyJun 25, 2025
Target
$45.00
Current
$37.52
Performance
-3.79%
WAY was rated Buy by Daniel Grosslight on Jun 25, 2025, with a price objective of 45. The stock is in a wait-and-see zone, leaving the Buy case open-ended.
CAH
HoldJun 13, 2025
Target
$170.00
Current
$158.68
Performance
-1.69%
On Jun 13, 2025, Daniel Grosslight initiated coverage on CAH with a Neutral rating and target of 170. The stock’s lack of movement around 158.68 aligned with a cautious approach.
HIMS
SellMar 06, 2025
Target
$27.00
Current
$49.36
Performance
43.53%
Daniel Grosslight issued a Sell recommendation for HIMS on Mar 06, 2025, price target set at 27. The bearish outlook played out, as shares fell from 49.36 to 49.36.
EVH
BuyJan 10, 2025
Target
$18.00
Current
$8.18
Performance
-34.77%
On Jan 10, 2025, EVH was evaluated by Daniel Grosslight, who gave a Buy rating and target of 18. Investors saw limited payoff as shares fell short of the 18 target.
PHR
BuyJan 10, 2025
Target
$35.00
Current
$23.11
Performance
-13.38%
Daniel Grosslight rated PHR as Buy on Jan 10, 2025, setting a price target of 35. The stock has underperformed, dropping 13.38% despite the bullish target of 35.
MPLN
HoldJan 10, 2025
Target
$12.50
Current
$23.15
Performance
81.85%
On Jan 10, 2025, MPLN was given a Neutral rating by Daniel Grosslight, with a target price of 12.5. The stock rallied from 23.15 to 23.15 after the Hold rating, surprising to the upside.
GDRX
BuyJan 10, 2025
Target
$6.25
Current
$3.89
Performance
-14.51%
GDRX received a Buy rating from Daniel Grosslight on Jan 10, 2025, aiming for 6.25. The rating hasn’t played out as hoped, with the stock trading 14.51% below expectations.